We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

748. Deputy Claire Kerrane asked the Minister for Health the reason a drug (details supplied) is not accessible in Ireland to cancer patients despite approval by the European Medicines Agency and its accessibility in many other parts of the EU and in the North of Ireland, if she will examine this and make the drug available for cancer patients where their oncology team has recommended it; and if she will make a statement on the matter. [52886/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this